Laurencia okamurai extract containing laurinterol induces apoptosis in melanoma cells

Journal of Medicinal Food

Volumn 11, Issue 2, 2008, Pages 260-266

  Kim, Moon Moo ^a   Mendis, Eresha ^b   Kim, Se Kwon ^c  

^a Dong Eui University   (South Korea)

^b UNIVERSITY OF PERADENIYA   (Sri Lanka)

^c Pukyong National University   (South Korea)

Author keywords

Apoptosis; B16F1 melanoma cells; Caspase; Laurencia okamurai; Laurinterol; p53

Indexed keywords

1 (4,5 DIMETHYLTHIAZOL 2 YL) 2,5 DIPHENYL 2H TETRAZOLIUM BROMIDE; CASPASE; DNA NUCLEOTIDYLEXOTRANSFERASE; LAURENCIA OKAMURAI EXTRACT; LAURINTEROL; PLANT EXTRACT; PROTEIN P21; PROTEIN P53; TETRAZOLE DERIVATIVE;

ANIMAL CELL; ANIMAL TISSUE; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL CYCLE; CONTROLLED STUDY; DNA FRAGMENTATION; ENZYME ACTIVITY; GENETIC TRANSCRIPTION; LAURENCIA; MELANOMA; MELANOMA CELL; MOUSE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPORTER GENE; TRANSCRIPTION INITIATION; WESTERN BLOTTING;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL LINE, TUMOR; DNA FRAGMENTATION; IN SITU NICK-END LABELING; LAURENCIA; MELANOMA; MELANOMA, EXPERIMENTAL; PLANT EXTRACTS; SESQUITERPENES; TUMOR SUPPRESSOR PROTEIN P53;

LAURENCIA;

EID: 46749123911     PISSN: 1096620X     EISSN: None     Source Type: Journal    
DOI: 10.1089/jmf.2007.575     Document Type: Article

References (27)

1. Henry H, Thomas A, Shen Y, White E: Regulation of the mitochondrial checkpoint in p53-mediated apoptosis confers resistance to cell death. Oncogene 2002;21:748-760.
2. Cheng SL, Liu RH, Sheu JN, Chen ST, Sinchaikul S, Tsay GJ: Toxicogenomics of A375 human malignant melanoma cells treated with arbutin. Biomed Sci 2007;14:87-105.
3. Yuru M, Shijun K, David A, Fishmana C: Lysophosphatidic acid inhibits anti-Fas-mediated apoptosis enhanced by actin depolymerization in epithelial ovarian cancer. FEBS Lett 2005:579:1311-1319.
4. Ryan KM, Vousden KH: Characterization of structural p53 mutants which show selective defects in apoptosis, but not cell cycle arrest. Mol Cell Biol 1998;18:3692-3698.
5. Lin D, Shields MT, Ullrich SJ, Appela E, Mercer WE: Growth arrest induced by wild-type p53 protein blocks cells prior to or near the restriction point in late G1 phase. Proc Natl Acad Sci U S A 1992;89:9210-9214.
6. Yu HS, Liao WT, Chai CY: Arsenic carcinogenesis in the skin. J Biomed Sci 2006;13:657-666.
7. Sakahira H, Enari M, Nagata S: Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature 1998;39:96-99.
8. Kim, SG, Ravi G, Hoffmann C, Jung YJ, Kim M, Chen A, Jacobson KA: p53-independent induction of Fas and apoptosis in leukemic cells by an adenosine derivative, Cl-IB-MECA. Biochem Pharmacol 2002;6:871-880.
9. Simmons TL, Andrianasolo E, McPhail K, Flatt P, Gerwick WH: Marine natural products as anticancer drugs. Mol Cancer Ther 2005;4:333-342.
10. Suzuki M, Kurosawa E: Halogenated and nonhalogenated aromatic sesquiterpenes from the red algae Laurencia okamurai Yamada. Bull Chem Soc Jpn 1979;52:3352-3354.
11. Sims JJ, Donnell MS, Leary JV, Lacy GH: Antimicrobial agents from marine algae. Antimicrob Agents Chemother 1975;7:320-321.
12. Hansen MB, Nielsen SE, Berg K: Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol Methods 1989;11:203-210.
13. Lin MT, Wang F, Uitto J, Yoon K: Differential expression of tissue-specific promoters by gene gun. Br J Dermatol 2001;14:34-39.
14. Virgili G, Gatta G, Ciccolallo L, Capocaccia R, Biggeri A, Crocetti E, Lutz JM, Paci E; EUROCARE Working Group: Incidence of uveal melanoma in Europe. Ophthalmology 2007;114:2309-2315.
15. Basma H, El-Refaey H, Sgagias MK, Cowan KH, Luo X, Cheng PW: BCL-2 antisense and cisplatin combination treatment of MCF-7 breast cancer cells with or without functional p53. J Biomed Sci 2005;12:999-1011.
16. Guchelaar HJ, Vermes A, Vermes I, Haanen C: Apoptosis: molecular mechanisms and implications for cancer chemotherapy. Pharm World Sci 1997;19:119-125.
17. Manson MM, Gescher A, Hudson EA, Plummer SM, Squires MS, Prigent SA: Blocking and suppressing mechanism of chemoprevention by dietary constituents. Toxicol Lett 2000;113:499-505.
18. Carter GT, Rinehart KL Jr, Li LH, Kuentzel SL, Connor JL: Brominated indoles from Laurencia brongniartii. Tetrahedron Lett 1978;19:4479-4482.
19. Vairappan CS, Daitoh M, Suzuki M, Abe T, Masuda M: Antibacterial halogenated metabolites from the Malaysian Laurencia species. Phytochemistry 2001;58:291-297.
20. Lin HH, Hsu HL, Yeh NH: Apoptotic cleavage of NuMA at the C-terminal end is related to nuclear disruption and death amplification. J Biomed Sci 2007;14:681-694.
21. Tewari M, Quan LT, O'Rourke K, Desnoyers S, Zeng Z, Beidler DR, Poirier GG, Salvesen GS, Dixit VM: Yama/CPP32 beta, a mammalian homolog for CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell 1995;81:801-809.
22. Janicke RU, Sprengart ML, Wati MR, Porter AG: Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J Biol Chem 1998;27:9357-9360.
23. Wu GS, Ding Z: Caspase-9 is required for p53-independent apoptosis and chemosensitivity in a human ovarian cancer cell line. Oncogene 2002;2:1-8.
24. Levine AJ: p53, the cellular gatekeeper for growth and division. Cell 1997;88:323-331.
25. Velculescu VE, El-Deiry WS: Biological and clinical importance of the p53 tumor suppressor gene. Clin Chem 1996;42:858-868.
26. Cirielli C, Riccioni T, Yang C, Pili R, Gloe T, Chang J, Inyaku K, Passaniti A, Capogrossi MC: Adenovirus-mediated gene transfer of wild-type p53 results in melanoma cell apoptosis in vitro and in vivo. Int J Cancer 1995;63:673-679.
27. Li G, Tang L, Zhou X, Tron V, Ho V: Chemotherapy-induced apoptosis in melanoma cells is p53 dependent. Melanoma Res 1998;8:17-23.